These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36072656)

  • 1. Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma.
    Huili Y; Nie S; Zhang L; Yao A; Liu J; Wang Y; Wang L; Cao F
    Front Genet; 2022; 13():958547. PubMed ID: 36072656
    [No Abstract]   [Full Text] [Related]  

  • 2. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
    Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
    Front Genet; 2022; 13():938259. PubMed ID: 35910212
    [No Abstract]   [Full Text] [Related]  

  • 3. The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma.
    Zhang L; Di L; Liu J; Lei X; Gu M; Zhang W; Wang Y
    Front Genet; 2023; 14():1039813. PubMed ID: 36755568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a novel 5 cuproptosis-related long noncoding RNA signature to predict diagnosis, prognosis, and drug therapy in clear cell renal cell carcinoma.
    Chen Y; Hu W; Wei X; Zhang L; Shao Y; Tian J; Wang D; Wu B
    Transl Androl Urol; 2023 Apr; 12(4):622-641. PubMed ID: 37181235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Validation of Cuproptosis-Related LncRNA Signatures in the Prognosis and Immunotherapy of Clear Cell Renal Cell Carcinoma Using Machine Learning.
    Bai Z; Lu J; Chen A; Zheng X; Wu M; Tan Z; Xie J
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The core genes of cuproptosis assists in discerning prognostic and immunological traits of clear cell renal cell carcinoma.
    Chu B; Hong Z; Zheng X
    Front Oncol; 2022; 12():925411. PubMed ID: 36212447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma.
    Mei W; Liu X; Jia X; Jin L; Xin S; Sun X; Zhang J; Zhang B; Chen Y; Che J; Ma W; Ye L
    Front Genet; 2022; 13():905518. PubMed ID: 36092880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L; Yu J; Tao L; Huang H; Gao Y; Yao J; Liu Z
    Front Genet; 2022; 13():947551. PubMed ID: 35938003
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma.
    Feng R; Li H; Meng T; Fei M; Yang C
    Discov Oncol; 2024 May; 15(1):187. PubMed ID: 38797784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and immune landscape of cuproptosis-related lncRNAs in kidney renal clear cell carcinoma: a bioinformatical analysis.
    Li D; Wu X; Song W; Cheng C; Hao L; Zhang W
    Ann Transl Med; 2022 Nov; 10(22):1235. PubMed ID: 36544675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network.
    Xiao Z; Zhang M; Shi Z; Zang G; Liang Q; Hao L; Dong Y; Pang K; Wang Y; Han C
    J Oncol; 2023; 2023():4643792. PubMed ID: 36949898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Validation of a Novel Cuproptosis-Related Seven-lncRNA Signature to Predict the Outcomes, Immunotherapeutic Responses, and Targeted Therapy in Patients with Clear Cell Renal Cell Carcinoma.
    Zhang H; Ning Z; Wang B; Liu Y; Tao B; Zhang G; Liu H; Wang C
    Dis Markers; 2023; 2023():7219794. PubMed ID: 36741910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma.
    Zhu M; Li Y; Wang Y; Lin P; Mi J; Zhong W
    Eur J Med Res; 2023 Jul; 28(1):248. PubMed ID: 37481601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
    Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
    Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
    Feng A; He L; Chen T; Xu M
    Front Oncol; 2022; 12():957966. PubMed ID: 36106123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.
    Wang B; Song Q; Wei Y; Wu X; Han T; Bu H; Tang S; Qian J; Shao P
    Front Immunol; 2022; 13():948042. PubMed ID: 36275737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer.
    Hou D; Tan JN; Zhou SN; Yang X; Zhang ZH; Zhong GY; Zhong L; Yang B; Han FH
    Front Genet; 2022; 13():969845. PubMed ID: 36105091
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential Role of Cuproptosis-Related Lncrna in Prognosis and Immunotherapy of Thyroid Carcinoma.
    Cai Y; Niu B; Gao J; Su H
    Iran J Public Health; 2023 May; 52(5):995-1007. PubMed ID: 37484723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma.
    Shi Y; Sheng P; Guo M; Chen K; Zhou H; Wu M; Li W; Li B
    Front Genet; 2023; 14():1100909. PubMed ID: 37470034
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.